Data / Form D filings / Aviv Pharma Inc.
Aviv Pharma Inc.: Form D filing
Aviv Pharma Inc., a pharmaceuticals company in Reno, NV, filed a Form D with the SEC in 2023. The latest, on December 28, 2023, reports $2.3 million sold of a $4 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 401 RYLAND STREET, SUITE 200A, Reno, NV, 89502
- Phone
- (917) 913-0408
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Nevada
- Year incorporated
- 2022
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 2005438
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 28, 2023 | New notice | $4,000,000 | $2,252,517 | $1,747,483 | 12 | Dec 15, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeffrey Alan Glazer | Executive Officer, Director | |
| Robert Rene Rabalais | Director | |
| Ricardo Alberto Hungria | Director | |
| Philip Arthur Epstein | Executive Officer, Director | |
| Jeffrey David Rosenberg | Director |
Every Form D from the week of Dec 25, 2023 · All recent filings in Nevada · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Aviv Pharma Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.